Related Articles

• Dynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukemia with low‑intermediate risk
• Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all‑trans retinoic acid and arsenic compound‑based combined therapies
• Evaluation of the efficacy of maintenance therapy for low-to-intermediate-risk acute promyelocytic leukemia in molecular remission: A retrospective single-institution study
• Pregnant woman with acute promyelocytic leukemia delivers healthy twins and is cured successfully: A case report
• Pregnancy-induced hypertension caused by all-trans retinoic acid treatment in acute promyelocytic leukemia. A case report